Report Detail

Other Global Pancreatic Cancer Therapy Market Size, Status and Forecast 2019-2025

  • RnM3412725
  • |
  • 12 July, 2019
  • |
  • Global
  • |
  • 97 Pages
  • |
  • QYResearch
  • |
  • Other

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Pancreatic Cancer Therapy Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Biology
      • 1.4.3 Chemotherapy
      • 1.4.4 Targeted Therapy
      • 1.4.5 Others
    • 1.5 Market by Application
      • 1.5.1 Global Pancreatic Cancer Therapy Market Share by Application (2014-2025)
      • 1.5.2 Hospitals
      • 1.5.3 Clinics
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Pancreatic Cancer Therapy Market Size
    • 2.2 Pancreatic Cancer Therapy Growth Trends by Regions
      • 2.2.1 Pancreatic Cancer Therapy Market Size by Regions (2014-2025)
      • 2.2.2 Pancreatic Cancer Therapy Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Pancreatic Cancer Therapy Market Size by Manufacturers
      • 3.1.1 Global Pancreatic Cancer Therapy Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Pancreatic Cancer Therapy Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Pancreatic Cancer Therapy Market Concentration Ratio (CR5 and HHI)
    • 3.2 Pancreatic Cancer Therapy Key Players Head office and Area Served
    • 3.3 Key Players Pancreatic Cancer Therapy Product/Solution/Service
    • 3.4 Date of Enter into Pancreatic Cancer Therapy Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Pancreatic Cancer Therapy Market Size by Type (2014-2019)
    • 4.2 Global Pancreatic Cancer Therapy Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Pancreatic Cancer Therapy Market Size (2014-2019)
    • 5.2 Pancreatic Cancer Therapy Key Players in United States
    • 5.3 United States Pancreatic Cancer Therapy Market Size by Type
    • 5.4 United States Pancreatic Cancer Therapy Market Size by Application

    6 Europe

    • 6.1 Europe Pancreatic Cancer Therapy Market Size (2014-2019)
    • 6.2 Pancreatic Cancer Therapy Key Players in Europe
    • 6.3 Europe Pancreatic Cancer Therapy Market Size by Type
    • 6.4 Europe Pancreatic Cancer Therapy Market Size by Application

    7 China

    • 7.1 China Pancreatic Cancer Therapy Market Size (2014-2019)
    • 7.2 Pancreatic Cancer Therapy Key Players in China
    • 7.3 China Pancreatic Cancer Therapy Market Size by Type
    • 7.4 China Pancreatic Cancer Therapy Market Size by Application

    8 Japan

    • 8.1 Japan Pancreatic Cancer Therapy Market Size (2014-2019)
    • 8.2 Pancreatic Cancer Therapy Key Players in Japan
    • 8.3 Japan Pancreatic Cancer Therapy Market Size by Type
    • 8.4 Japan Pancreatic Cancer Therapy Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Pancreatic Cancer Therapy Market Size (2014-2019)
    • 9.2 Pancreatic Cancer Therapy Key Players in Southeast Asia
    • 9.3 Southeast Asia Pancreatic Cancer Therapy Market Size by Type
    • 9.4 Southeast Asia Pancreatic Cancer Therapy Market Size by Application

    10 India

    • 10.1 India Pancreatic Cancer Therapy Market Size (2014-2019)
    • 10.2 Pancreatic Cancer Therapy Key Players in India
    • 10.3 India Pancreatic Cancer Therapy Market Size by Type
    • 10.4 India Pancreatic Cancer Therapy Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Pancreatic Cancer Therapy Market Size (2014-2019)
    • 11.2 Pancreatic Cancer Therapy Key Players in Central & South America
    • 11.3 Central & South America Pancreatic Cancer Therapy Market Size by Type
    • 11.4 Central & South America Pancreatic Cancer Therapy Market Size by Application

    12 International Players Profiles

    • 12.1 Eli Lilly
      • 12.1.1 Eli Lilly Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Pancreatic Cancer Therapy Introduction
      • 12.1.4 Eli Lilly Revenue in Pancreatic Cancer Therapy Business (2014-2019)
      • 12.1.5 Eli Lilly Recent Development
    • 12.2 Roche
      • 12.2.1 Roche Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Pancreatic Cancer Therapy Introduction
      • 12.2.4 Roche Revenue in Pancreatic Cancer Therapy Business (2014-2019)
      • 12.2.5 Roche Recent Development
    • 12.3 Pfizer
      • 12.3.1 Pfizer Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Pancreatic Cancer Therapy Introduction
      • 12.3.4 Pfizer Revenue in Pancreatic Cancer Therapy Business (2014-2019)
      • 12.3.5 Pfizer Recent Development
    • 12.4 Merck
      • 12.4.1 Merck Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Pancreatic Cancer Therapy Introduction
      • 12.4.4 Merck Revenue in Pancreatic Cancer Therapy Business (2014-2019)
      • 12.4.5 Merck Recent Development
    • 12.5 Celgene
      • 12.5.1 Celgene Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Pancreatic Cancer Therapy Introduction
      • 12.5.4 Celgene Revenue in Pancreatic Cancer Therapy Business (2014-2019)
      • 12.5.5 Celgene Recent Development
    • 12.6 Novartis
      • 12.6.1 Novartis Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Pancreatic Cancer Therapy Introduction
      • 12.6.4 Novartis Revenue in Pancreatic Cancer Therapy Business (2014-2019)
      • 12.6.5 Novartis Recent Development
    • 12.7 Amgen
      • 12.7.1 Amgen Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Pancreatic Cancer Therapy Introduction
      • 12.7.4 Amgen Revenue in Pancreatic Cancer Therapy Business (2014-2019)
      • 12.7.5 Amgen Recent Development
    • 12.8 Teva Pharmaceutical
      • 12.8.1 Teva Pharmaceutical Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Pancreatic Cancer Therapy Introduction
      • 12.8.4 Teva Pharmaceutical Revenue in Pancreatic Cancer Therapy Business (2014-2019)
      • 12.8.5 Teva Pharmaceutical Recent Development
    • 12.9 PharmaCyte Biotech
      • 12.9.1 PharmaCyte Biotech Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Pancreatic Cancer Therapy Introduction
      • 12.9.4 PharmaCyte Biotech Revenue in Pancreatic Cancer Therapy Business (2014-2019)
      • 12.9.5 PharmaCyte Biotech Recent Development
    • 12.10 Clovis Oncology
      • 12.10.1 Clovis Oncology Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Pancreatic Cancer Therapy Introduction
      • 12.10.4 Clovis Oncology Revenue in Pancreatic Cancer Therapy Business (2014-2019)
      • 12.10.5 Clovis Oncology Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Pancreatic cancer therapy is recommended by clinicians for early detection of cancer. Pancreatic cancer generally diagnosed at a later stage, since the symptoms are not easily detected or diagnosed. Factors such as, chronic inflammation of the pancreas (pancreatitis), diabetes, smoking, and obesity are some of the identified causes of pancreatic cancer.
      In May 2018, Eli Lilly and Company acquired AMRO BioSciences. AMRO BioSciences is engaged into number of drugs for cancer. The clinical trial explores a drug (pegilodecakin) which is ongoing for the pancreatic cancer. The drug is into phase III of the clinical trials. The acquisition will enhance the therapy products for the Eli Lilly and Company.
      In 2018, the global Pancreatic Cancer Therapy market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Pancreatic Cancer Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pancreatic Cancer Therapy development in United States, Europe and China.

      The key players covered in this study
      Eli Lilly
      Roche
      Pfizer
      Merck
      Celgene
      Novartis
      Amgen
      Teva Pharmaceutical
      PharmaCyte Biotech
      Clovis Oncology

      Market segment by Type, the product can be split into
      Biology
      Chemotherapy
      Targeted Therapy
      Others

      Market segment by Application, split into
      Hospitals
      Clinics
      Others

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Pancreatic Cancer Therapy status, future forecast, growth opportunity, key market and key players.
      To present the Pancreatic Cancer Therapy development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Pancreatic Cancer Therapy are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


      Summary:
      Get latest Market Research Reports on Pancreatic Cancer Therapy. Industry analysis & Market Report on Pancreatic Cancer Therapy is a syndicated market report, published as Global Pancreatic Cancer Therapy Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Pancreatic Cancer Therapy market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,041.07
      4,561.60
      6,082.14
      3,514.42
      5,271.63
      7,028.85
      423,957.30
      635,935.95
      847,914.60
      277,890.60
      416,835.90
      555,781.20
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report